Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
EDIT compared with ZLAB: revenue, margins and what each company keeps, and the suppliers and customers both name
EDIT
Editas Medicine, Inc.
Change
Mkt cap
Revenue
Revenue
ZLAB
Zai Lab Ltd
Change
Mkt cap
Revenue
Revenue
vs
Compare
EDIT
Editas Medicine, Inc.
vs
ZLAB
Zai Lab Ltd
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
EDIT
with
ZLAB
Uncorrelated: r 0.25 · 499D.
Shared co-movers
1
with EDIT
with ZLAB
RXRX
Recursion Pharmaceuticals, Inc.
r 0.47
r 0.30
EDIT, solid
ZLAB, hatched
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
EDIT
Editas Medicine, Inc.
Change
2.65
▼
−9.48%
· post 2.62
Mkt cap
$410.1M
Revenue
$12M
Q2 FY26
Revenue
—
ZLAB
Zai Lab Ltd
Change
22.09
▼
−1.21%
· post 22.10
Closed
Oct 30 '26
Mkt cap
$2.5B
Revenue
$106M
Q2 FY26
Revenue
$460M
FY25
vs
Compare
Closed
Oct 30 '26
EDIT
Editas Medicine, Inc.
vs
ZLAB
Zai Lab Ltd
2.65
▼
−9.48%
post 2.62
Price
22.09
▼
−1.21%
post 22.10
$410.1M
Mkt cap
$2.5B
Q2 FY26
$12M
Revenue
$106M
Q2 FY26
—
Revenue
$460M
FY25
Change
Change
EDIT
2.65
▼
−9.48%
vs
ZLAB
22.09
▼
−1.21%
Closed
Oct 30 '26